A detailed history of Northstar Advisory Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Northstar Advisory Group, LLC holds 55,801 shares of PFE stock, worth $1.48 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
55,801
Previous 8,311 571.41%
Holding current value
$1.48 Million
Previous $232,000 595.69%
% of portfolio
0.84%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $1.32 Million - $1.49 Million
47,490 Added 571.41%
55,801 $1.61 Million
Q2 2024

Aug 01, 2024

BUY
$25.26 - $29.6 $209,935 - $246,005
8,311 New
8,311 $232,000
Q2 2022

Jul 11, 2022

SELL
$46.53 - $55.17 $5,490 - $6,510
-118 Reduced 1.77%
6,559 $344,000
Q1 2022

Apr 14, 2022

BUY
$45.75 - $56.69 $2,424 - $3,004
53 Added 0.8%
6,677 $346,000
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $273,703 - $405,720
6,624 New
6,624 $391,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Northstar Advisory Group, LLC Portfolio

Follow Northstar Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northstar Advisory Group, LLC with notifications on news.